Forget Ozempic: This High-Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
Eli Lilly (NYSE: LLY) is the leader in the field, but some will argue that its shares are overvalued. Novo Nordisk (NYSE: NVO) -- the maker of popular drugs like Ozempic and Wegovy -- is second, but it has faced significant clinical setbacks in recent years and expects its revenue to decline in 2026. Many other drugmakers are working on weight loss medicines. However, some are smaller biotechs that carry significant risk, and even when they are larger, well-established companies, they are still some ways away from making a dent in this space. Fortunately, there is a way to cash in on this market regardless of who wins the weight-loss drug battle: invest in a medical device specialist like Dexcom (NASDAQ: DXCM) Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. Dexcom may benefit from
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Baird Small/Mid Cap Growth Q1 2026 Commentary [Seeking Alpha]Seeking Alpha
- DXCM STOCKHOLDER NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Investors to Contact the FirmGlobeNewswire
- A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher [Yahoo! Finance]Yahoo! Finance
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- DexCom's Quarterly Earnings Preview: What You Need to Know [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/12/26 - Beat
DXCM
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form ARS
- 4/15/26 - Form DEFA14A
- DXCM's page on the SEC website